A Novel Theranostic Strategy for Malignant Pulmonary Nodules by Targeted CECAM6 with 89Zr/131I‐Labeled Tinurilimab

A Novel Theranostic Strategy for Malignant Pulmonary Nodules by Targeted CECAM6 with 89Zr/131I‐Labeled Tinurilimab

Abstract Lung adenocarcinoma (LUAD) constitutes a major cause of cancer‐related fatalities worldwide. Early identification of malignant pulmonary nodules constitutes the most effective approach to reducing the mortality of LUAD. Despite the wide application of low‐dose computed tomography (LDCT) in...

Full description

Saved in:
Bibliographic Details
Main Authors: Chongyang Chen, Keying Zhu, Jing Wang, Donghui Pan, Xinyu Wang, Yuping Xu, Junjie Yan, Lizhen Wang, Min Yang
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Advanced Science
Subjects:
89Zr/131I‐labeled tinurilimab
CEACAM6
LUAD
malignant pulmonary nodules
PET/MR
theranostics
Online Access:https://doi.org/10.1002/advs.202415689
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items